Elimination of sulfamethazine residues from swine.

Tissue concentrations of sulfamethazine in swine fed the drug at the rate of 500 g/ton of ration (550 g/1,000 kg) for a 30-day period depleted to 0.1 ppm or less within 4 to 10 days after withdrawal of medicated feed. Depletion from the tissues and plasma of treated pigs showed a linear relationship with time when the concentrations were plotted on a semilogarithmic graph. Six untreated pigs that were placed on bedding in pens formerly occupied by the treated group developed tissue residues at or above 0.1 ppm sulfamethazine; the mean plasma concentration of sulfamethazine reached 2.8 ppm by day 15.     

Tissue sulfonamide concentration and correlation in turkeys

Nineteen hen turkeys (10 to 12 kg each) were used in a feeding study to determine sulfadimethoxine and sulfaquinoxaline concentrations in blood serum, liver, and skeletal muscle, as well as the respective ratios at selected withdrawal intervals. Two feeds were prepared by use of premixes to achieve 60 mg of sulfadimethoxine/kg and 100 mg of sulfaquinoxaline/kg, respectively. Each of the medicated feeds was given to 9 turkeys for 7 days. The turkeys were then fed nonmedicated feed at intervals from 24 to 56 hours and were slaughtered. One turkey was used as control. The serum/liver and serum/muscle ratios for sulfaquinoxaline were 60 to 70% higher than for sulfadimethoxine. However, the liver/muscle ratio for both sulfonamides was equivalent, approximately 3. Disposition of both sulfonamides approximated first-order pharmacokinetics. The calculated half-life of sulfadimethoxine was half that of sulfaquinoxaline, approximately 16 vs 30 hours. The coefficients of variation in the serum/tissue ratios for both sulfonamides were between 13% and 25% for serum/liver and less than 15% for serum/muscle, indicating excellent potential for using serum as a predictor of actionable concentrations of sulfonamide residues.     

Persistence of transferable drug resistance in the lactose-fermenting enteric flora of swine following antimicrobial feeding.

Six groups of swine (85 animals) were fed a combination of antimicrobial drugs (sulfamethazine 100 g/ton, chlortetracycline 100 g/ton and penicillin 50 g/ton). After two weeks the antimicronial drugs were removed from the diet of two groups (28 animals). These swine were compared to four groups fed the medicated diet to determine the effect of duration of treatment and degree of animal isolation on the persistence of resistance in lactose-fermenting enteric organisms. The degree of resistance to penicillin, oxytetracycline, dihydrostreptomycin and neomycin as determined by minimum inhibitory concentrations and the incidence of resistant organisms were examined during and after antibiotic feedings. Ninety-two percent or greater of all isolates tested during and after treatment had minimum inhibitory concentrations for oxytetracycline of greater than 100 mug/ml. Thirty-two weeks after cessation of dietary antibiotic, resistance to oxytetracycline and dihydrostreptomycin remained at 100% and 89% respectively. Variation in degree of contact between swine receiving medicated feed and those receiving nonmedicated feed was not sufficient to reduce the incidence of resistance to oxytetracycline or dihydrostreptomycin in all animals. Factors influencing persistence of resistant enteric organisms are discussed. Addition of the antimicrobials to the ration resulted in significantly greater weight gains for treated animals than for the controls but did not alter feed conversion.     

Vitamin B12 and monensin effects on performance, liver and serum vitamin B12 concentrations and activity of propionate metabolizing hepatic enzymes in feedlot lambs

Monensin in ruminant diets increases production of propionic acid. We have tested the hypothesis that propionic acid may be elevated to such an extent by monensin that it cannot be optimally metabolized by the methyl malonyl-CoA pathway requiring vitamin B12 (B12) in the liver. Thus, the effects of weekly B12 injections (10 mg X head-1 X wk-1, intramuscularly) with and without dietary monensin (25 mg/kg diet) on average daily gain (ADG), dry matter intake (DMI), feed to gain ration (F/G), liver and serum B12 concentrations and liver activity of propionate metabolizing enzymes were examined in an 84-d trial. Sixteen lambs (27.5 kg average initial wt) were assigned randomly to one of four treatments in a factorial arrangement: monensin plus B12, monensin without B12, no monensin plus B12 and no monensin without B12. Lambs were fed an 80% concentrate diet and slaughtered at the end of the trial. Liver samples were obtained by biopsy on d 0 and at slaughter on d 84 to determine activity of propionate metabolizing enzymes and B12 concentrations. Serum samples were taken on d 0, 28, 56 and 84 to determine serum B12 concentration. Neither monensin nor B12 affected (P greater than .10) ADG, DMI or F/G. Lambs receiving B12 had higher (P less than .01) serum B12 concentrations, but this was not reflected (P greater than .10) in higher liver B12 concentrations. No difference (P greater than .10) in liver propionate metabolizing activity among treatments was detected; however, monensin decreased (P less than .05) fumarate and malate formation by liver homogenates. Liver B12 concentrations were highly correlated with endogenous propionate metabolizing activity at d 0 (r = .73, P less than .01) and d 84 (r = .51, P less than .05). Results suggest no advantage to providing supplemental B12 to lambs fed monensin-supplemented, high-concentrate diets.     

磺胺二甲嘧啶在黑鲪体内的药物代谢动力学和残留消除研究

在(14±1)℃水温条件下,对黑鲪单次口灌100 mg/kg体重的磺胺二甲嘧啶,进行药物代谢动力学研究。在(20±2)℃水温条件下,按照《中华人民共和国水产行业标准磺胺类药物水产养殖使用规范》推荐剂量对黑鮶连续5天口灌给予磺胺二甲嘧啶,研究其在黑鮶体内的残留消除规律。血浆、肌肉和肝脏样品采用高效液相色谱检测,DAS2.0药物代谢动力学软件对数据进行处理分析。结果表明磺胺二甲嘧啶在黑鲪血浆、肌肉和肝脏中均符合一室模型,肝脏、血液和肌肉中药物达峰时间分别为6 h,8 h和10 h;峰值浓度分别为26.45μg/g、25.57μg/g和31.15μg/g;连续多次给药后,黑鮶血液、肌肉、肝脏中药物浓度分别在给药后12d、14d、15d后小于最大残留限量要求(0.1mg/kg)。     

Ascariasis, respiratory diseases and production indices in selected Prince Edward Island swine herds.

The levels of production, ascarid burden and respiratory disease were measured on 15 purposively selected swine herds, and the relationships between the various measures of ascarid burden were examined. On each farm 30 randomly selected pigs were weighed and rectal fecal samples were collected at approximately 11, 15, 19 and 22 weeks of age, and at slaughter. Fecal ascarid-egg counts and duration of infection were combined to calculate a composite measure of ascarid burden called "lifetime burden". At the abattoir the carcass weight and levels of anteroventral pneumonia, atrophic rhinitis, and liver lesions were recorded for each hog. The number of ascarids in the small intestines were counted. Study hogs were marketed at an average of 189 +/- 22 days. The average dressed carcass weight was 77.0 +/- 5.9 kg and the mean average daily gain was 0.519 +/- 0.071 kg/day. The percent of hogs with ascariasis varied widely among farms, no matter what measure of ascariasis was used; the percent with intestinal ascarids at slaughter ranged from 0% to 96%, the percent that shed ascarid eggs during their lifetime ranged from 0% to 100%, and the range for hogs with liver lesions ranged from 27% to 100%. Of the hogs slaughtered, 82% had milk spot lesions, 32% shed ascarid eggs during their lifetime and 35% had intestinal ascarids. The latter had an average of 12 intestinal ascarids. Anteroventral pneumonia occurred in 55% of the slaughtered hogs and 9% had atrophic rhinitis scores of five. The percent of hogs per farm with pneumonia ranged from 17% to 96%. The percent of hogs per farm with atrophic rhinitis scores of five ranged from 0% to 57%.     

Effect of Dietary Mannan Oligosaccharide from Bio-Mos or SAF-Mannan on Live Performance of Broiler Chickens

A 42-d broiler pen trial was conducted to evaluate the effects of dietary mannan oligosaccharide (MOS) from either of 2 commercial products, Bio-Mos (Alltech Inc., Nicholasville, KY) or SAF-Mannan (S. I. LeSaffre, Cedex, France) each at 2 levels of inclusion on live performance. The MOS, derived from the outer portion of yeast cell walls, is reported to have several beneficial modes of action including 1) pathogen adsorption (agglutination); 2) improved intestinal integrity (e.g., villi height); and 3) immune modulation. Diets were fed in 3 phases, and treatments included a control, 2 Bio-Mos treatments (1.0 kg/ton in starter and 0 or 0.5 kg/ton in grower and finisher feeds), and 2 SAF-Mannan treatments (0.5 kg/ton in starter and 0 or 0.5 kg/ton in grower and finisher feeds), according to the manufacturers’ recommendations. Birds fed Bio-Mos at 1.0/0.5/0.5 (starter/grower/finisher) kg/ton diets had significantly greater BW at 42 d than birds fed control or SAF-Mannan-supplemented diets, whereas results for the Bio-Mos 1.0/0/0 kg/ton diets were intermediate. Supplementation of diets with Bio-Mos at 1.0/0.5/0.5 kg/ton may improve broiler BW at market ages compared with the unsupplemented diets. Feed consumption was lower from 0 to 21 d in the SAF-Mannan treatments compared with other treatments. No significant differences were found for feed conversion or mortality for any of the treatments. Overall, Bio-Mos had a greater effect on bird BW compared with the other variables measured.     

Influence of pregnancy on body weight, ruminal characteristics, and visceral organ mass in beef heifers

Crossbred heifers (initially 24 mo, approximate age and 378 +/- 32.1 kg BW) were used to evaluate the influence of pregnancy and advancing gestation on DMI, BW, carcass weight, ruminal characteristics, and visceral organ mass. Heifers (naturally serviced (n = 22; nonpregnant controls, n = 17), were grouped in common pens. Heifers were provided corn silage and hay-based diets formulated to provide 0.45 kg of ADG. Treatments were pregnancy and nonpregnancy; pregnant and nonpregnant heifers were slaughtered on d 40, 120, 200, and 270. Live weight at slaughter and BW change throughout the trial were not influenced by pregnancy (P > 0.1). Carcass weight per unit of BW was decreased due to pregnancy (P < 0.05) and an interaction was found in eviscerated BW (EvBW; P < 0.1), with the pregnant heifers having greater live weights, carcass weights, and EvBW at the d-200 slaughter period. Ruminal fluid fill and total fill (g/kg BW) declined as slaughter period advanced, resulting in the pregnant heifers having less fill at d 270 (P< 0.07). However, ME intake was not different between pregnant and nonpregnant heifers (P > 0.1) at any of the slaughter periods. Heart mass responded differently when nonpregnant and pregnant were analyzed over time and an interaction was detected as slaughter period advanced (P < 0.1). Liver, duodenum, jejunum, and large intestinal mass were not responsive to pregnancy (P > 0.1). Data indicate that ruminal fill is altered by pregnancy but visceral organ mass is not greatly changed by treatment.     

Coccidiostatic action of monensin fed to lambs: body weight gains and feed conversion efficacy.

Thirty crossbred ewe lambs weighing an average of 37.3 kg were allotted to 6 groups of 5 lambs each so that group weights were nearly equal. Lambs were fed dehydrated alfalfa pellets, initially at 1.14 kg/day and subsequently increased after experimental day 15 and 42. Each lamb was artificially infected with 18,000 sporulated oocysts of Eimeria ninakohlyakimovae. Groups 1, 2, 3, and 4 were given monensin in the form of medicated alfalfa pellets at dose levels of 5, 10, 20, and 30 g/metric ton, respectively. Groups 5 and 6 were infected controls (infected, nonmedicated). Lambs in groups 5 and 6 developed severe clinical coccidiosis, having diarrhea and losing weight rapidly. Group 1 lambs did not have diarrhea, but the lambs did not gain well. All other medicated lambs gained weight during the experimental period of 84 days. Feed conversion was good in medicated groups 2, 3, and 4 and was poor in control groups 5 and 6. Statistically significant differences in feed conversion and body weight gains (5 and 1% level of confidence) were observed between control and medicated groups.     

磺胺二甲嘧啶在麻黄鸡组织中残留消除规律研究

用添加临床剂量100 mg/kg磺胺二甲嘧啶的饲料喂养40日龄麻黄鸡,连续用药3 d,分别在停药0、12、24、48、72、96、120、144、192、240、360、480、600 h时间点对肌肉、肝和肾组织采样,检测磺胺二甲嘧啶残留浓度。停药25 d后,肌肉组织残留量为0.054 mg/kg,肝和肾组织未检出磺胺二甲嘧啶,结果表明磺胺二甲嘧啶在麻黄鸡组织中停药期为25 d,《中国兽药典》2005年版中规定磺胺二甲嘧啶10 d的停药期是不尽合理的。     

Patterns associated with season and facilities for atrophic rhinitis and pneumonia in slaughter swine.

Three slaughter checks were performed for each of 21 swine producers at 6-month intervals. Two slaughter checks were performed during the winter, and 1 slaughter check was performed during the summer. Lesions of atrophic rhinitis and pneumonia were evaluated during the slaughter checks. Two types of farrowing facilities and 4 types of grower/finisher facilities were used by the swine producers. Lesions of atrophic rhinitis and pneumonia were compared among seasons and among types of facilities. Lesions of both atrophic rhinitis and pneumonia varied with season. Lesions of atrophic rhinitis were more severe among hogs slaughtered in the summer, whereas lesions of pneumonia were more severe among hogs slaughtered in the winter. Lesions of atrophic rhinitis were more severe in hogs farrowed in central, enclosed farrowing houses and finished in enclosed, mechanically ventilated buildings than in hogs farrowed individually in sow huts and finished on dirt lots. Knowledge of disease patterns associated with season and facilities is useful for assessment of herd health status and for implementation of control programs.     

Elimination of sulfamethazine from edible tissues, blood, urine, and feces of turkey poults.

Sulfamethazine was administered to 8- to 10-week-old turkey poults intravenously (IV) at the dose level of 71.5 mg/kg of body weight, orally at the dose level of 143 mg/kg of body weight, or in the drinking water at the concentration of 0.1% over a 6-day period. The concentrations of free sulfamethazine in blood, muscle, skin, kidney, and liver were determined and semilogarithmic plots of concentration vs time for the various tissues indicated that the curve had a linear portion within the first 72-hour period of drug withdrawal. The rates of disappearance of sulfamethazine from the various tissues were proportional to the concentration in the tissues. After 72 hours of withdrawal and for as long as 14 days, sulfamethazine concentrations in kidney, liver, and skin of turkeys given the drug in the drinking water fluctuated between 0.1 and 0.4 ppm. Only 8.6% of the oral dose (143 mg/kg) and 16.5 to 17% of the IV dose (71.5 mg/kg) were recovered in urine and feces as the parent compound during the initial 72-hour period.     

Responses of Beijing black hogs to porcine somatotropin

Somatotropin treatment of U.S-breed finishing hogs improves feed efficiency, growth rate and carcass lean-to-fat ratio. Because Chinese-bred hogs have poorer feed efficiency, growth rate and lean-to-fat ratio than U.S. bred hogs, the characteristics affected by porcine somatotropin (PST) may respond differently to treatment. In the present experiment, Beijing Black finishing hogs (a composite of a local Chinese, Berkshire and Yorkshire breeds) were treated with PST for 28 d from average initial to final weights of 67.8 to 96.6 kg. In hogs individually fed as much as they would eat four times a day (n = 12/treatment group, six gilts and six barrows), feed efficiency was improved by 22.4 and 29.9% by 2 and 4 mg/d PST, respectively (P less than .01), primarily due to increased growth rate (22.1 and 32.6% greater than control, respectively, P less than .01); feed intake was not affected. Performance of group-housed and group-fed hogs (six/pen, four pens/treatment) administered 2 mg/d PST for 28 d (average initial and final weights of 66.5 +/- 1.7 and 94.0 +/- 2.4 kg, respectively) was similar (22.7% improved feed efficiency, P less than .01; 25% increased growth rate, P less than .01). At slaughter, last rib backfat thickness was decreased an average of 19.2% for hogs treated with 2 and 4 mg/d PST (P less than .01). Percentage of total muscle, obtained by physical separation of the half-carcass, was increased an average of 13.5% (P less than .01), whereas percentage of total fat was decreased 21.8% (P less than .01) in PST-treated hogs. The pH, water-holding capacity and meat color scores of longissimus muscle from PST-treated hogs did not differ from those of control hogs. Growth rate, feed efficiency and muscle weight responses to PST treatment were at least as large as those for U.S. breeds.     

Interrelationships of exogenous porcine growth hormone administration and feed intake level affecting various tissue levels of iron, copper, zinc and bone calcium of growing pigs

Trace mineral status was evaluated in a 2 x 3 factorial treatment array with a total of 34 barrows growing from 25 to 55 kg live weight. Treatments included three levels of feed intake (100, 80 and 60% of ad libitum intake) and exogenous pituitary growth hormone (pGH) therapy (0 and 100 micrograms/kg BW daily). Blood was collected prior to slaughter for the determination of hematocrit and serum trace metal concentrations; tissues (liver, heart, kidney, bone and muscle) were obtained when pigs were slaughtered at 55 kg. Hematocrits and serum Fe were lower in pGH-treated pigs than in controls at all levels of feed intake. Serum Cu was increased by feed restriction but was not altered by pGH therapy. The concentration of serum Zn was not affected by either treatment. Concentrations of hepatic Fe and Cu were lower in pGH-treated pigs than in controls but were higher in feed-restricted pigs than in ad libitum-fed pigs. However, the total amounts of hepatic Fe and Cu were similar in pGH-treated pigs to concentrations in controls. The concentration of hepatic Zn was not influenced by either pGH treatment or feed intake. Femur weights were marginally greater in pGH-treated pigs, probably due to elevated water content. Iron concentration in bone was higher in pGH-treated pigs than in control pigs, whereas Ca, Cu and Zn were not influenced by pGH treatment or feed restriction. Feed intake and pGH treatment did not influence the concentrations of Fe, Cu or Zn in muscle. These findings indicate that pGH therapy affects the metabolism of Fe but has little impact on the overall composition of body ash.     

Boluses of controlled release glass for supplementing ruminants with copper

A controlled release glass was formulated into boluses weighing approximately 17 g or 75 g and administered to 19 lambs and 20 steers respectively. The animals were at pasture during the summer months. The lambs were slaughtered between 57 and 219 days after dosing when the mean concentration of copper in their livers had increased to 107.8 +/- 33.4 mg copper/kg fresh weight compared with 55.9 +/- 23.0 mg copper/kg fresh weight in undosed controls. The steers were slaughtered more than 140 days after dosing; the mean concentrations of copper in plasma had increased and the mean concentration of copper in liver was significantly greater than in undosed control steers (14.1 +/- 4.8 mg copper/kg fresh weight liver in dosed steers, 4.7 +/- 1.4 mg copper/kg in control steers) and was similar to the concentration in steers which had received 200 mg copper as copper calcium edetate (18.2 +/- 4.2 mg copper/kg fresh weight). In sheep the minimum rate of release of copper into the reticulorumen was 2.1 mg/day and in steers 11 mg/day.     

The public health implications of farming cattle in areas with high background concentrations of vanadium

Forty-two adult Brahman-cross cattle farmed extensively in two groups, immediately adjacent to and 2 km from a vanadium processing plant respectively, were slaughtered over a 5 year period at a nearby abattoir. Cattle were being exposed to vanadium at close to no-adverse-effect levels. The dose of vanadium that cattle were taking in prior to slaughter was calculated for each animal from environmental and physiological data using a stochastic risk assessment model. The median exposure doses in the month prior to slaughter ranged from 0.55 to 2.73 mg vanadium/kg body weight/day. A range of tissues was taken from the cattle at slaughter for vanadium determination and tissue levels of vanadium in muscle, liver and kidney are reported. The concentrations of vanadium in the milk of cattle from the same farm sampled over 5 years are also reported. Concentrations were further modelled using a lognormal distribution function to look at possible extreme values that are likely to occur. The concentrations of vanadium in commonly consumed tissues ranged from <0.05 to 11.51 mg/kg (wet-mass basis). The median concentration of vanadium in milk was 0.23 mg vanadium/kg. People drinking milk were at highest risk. The potential oral daily intake of vanadium for people consuming these foodstuffs was modelled using a stochastic model. The model predicted that there is less than a 5% chance that the potential daily intake of vanadium from milk will be >0.44 μg/kg/day for adults. Based on this upper limit it was concluded from current knowledge of toxicity in humans that the tissue and milk residues from cattle should pose no health risk to the consumer.     

The effect of live weight gain and live weight loss on body composition of Merino wethers: dissected muscle, fat, and bone.

Sheep were slaughtered after live weight gain (LWG) and live weight loss (LWL) to evaluate the effect of different periods of normal and retarded growth on dissected carcass components. Thirty-five Merino wether sheep were allowed ad libitum access to the experimental diet of 80% alfalfa chaff and 20% cereal grain (17.23% CP and 18.10 MJ/kg of GE) to grow from 23.0 to 33.0 kg live weight and then fed to lose 10 kg at 133 g/d. Five animals were slaughtered at live weights of 23.0, 26.3, 29.6, and 33.0 kg during LWG and 29.6, 26.3, and 23.0 kg during LWL. Fleece-free empty BW was similar in both LWG and LWL animals at all common slaughter weights because of the lesser and greater weights of the alimentary tract contents and the fleece, respectively, in the LWL animals. Carcass weight or dissected side weight was greater in LWL animals at each common slaughter weight but significantly so (P less than .05) at the 23.0 kg live weight only. Total side muscle weight was similar in LWG and LWL animals at each common slaughter weight, but the proportion of muscle in the dissected side weight was lower (P less than .05) in LWL animals at 23.0 kg live weight. Total side fat, subcutaneous fat, intermuscular fat, and kidney and channel fat weights were all greater in LWL animals at each common slaughter weight, but significantly so (P less than .05) at the 23.0 kg live weight only. Total side bone weight was higher at both 26.3 kg (P less than .01) and 23.0 kg (P less than .05) in the LWL animals. Weight loss in young sheep mobilized more weight of muscle than fat from the carcass, whereas bone weight was constant.     

Efficacy against Fasciola hepatica and the pharmacokinetics of triclabendazole administered by oral and topical routes

Objective   To determine the efficacy of triclabendazole (TCBZ) against 28-day-old, early immature liver fluke in cattle and its pharmacokinetics following administration by the oral or topical (pour-on) route.
Procedures   Cattle (n = 18) were infected with 500 TCBZ-susceptible liver fluke metacercariae and randomly allocated to three groups. At 28 days after infection, the groups were: (1) untreated controls; (2) treated with oral TCBZ at 12 mg/kg in combination with oxfendazole and selenium (TOS); (3) treated with pour-on TCBZ at 30 mg/kg in combination with abamectin (TA). Blood samples were taken immediately prior to treatment and serially after treatment to assess the plasma profile of TCBZ metabolites. Ten weeks after treatment all animals were slaughtered and total liver fluke counts, fluke egg counts and liver pathology were assessed.
Results   Both the TOS and TA treatments resulted in significant reductions of 28-day-old liver fluke, as assessed by fluke counts and fluke egg counts at slaughter, and the reductions following TOS treatment were significantly greater than those following TA treatment. The blood profile of TCBZ metabolites in TOS-treated animals showed a significantly greater area under the plasma concentration time curve and a higher maximum observed concentration than those treated with TA. There was significantly less liver pathology in TOS-treated animals than in the TA-treated animals.
Conclusion   TCBZ administered orally at 12 mg/kg resulted in greater efficacy against 28-day-old, early immature liver fluke than was achieved by topical administration at 30 mg/kg. Plasma metabolites of TCBZ were higher and liver pathology was less in TOS-treated animals than in TA-treated animals.     

Evidence that bovine growth hormone treatment increases the rate of extrathyroidal 5'-monodeiodinase activity in cattle

This study examined the influence of bovine growth hormone (bGH) on liver and kidney thyroxine-5'-monodeiodinase activity (TMA) in growing beef cattle. In a preliminary trial (trial 1), tissue samples were obtained at slaughter from two placebo-injected and two bGH-injected (29.2 IU/day for 14 days before slaughter) Hereford heifers (398 kg avg slaughter wt), with one heifer on each treatment fed at either 1.0 or 2.0 times maintenance energy requirement. In a second trial, tissue and plasma samples were obtained from six placebo-injected and six bGH-injected (29.2 IU/day for 19 days) Hereford steers (331 kg avg slaughter wt) fed at 1.8 times maintenance energy requirement. In a third trial, liver tissue and plasma samples were obtained from 14 Angus X Hereford steers (270 kg avg wt) fed either an 8% protein, 1.96 Mcal-metabolizable energy/kg diet (8 steers) or a 14% protein, 2.67 Mcal-metabolizable energy/kg diet (6 steers) in association with acute administration of bGH. Half the steers in each group were given two injections per steer of either placebo or 37.8 IU bGH at 24-hr intervals and slaughtered 24 hr after the second injection. Units of tissue TMA in all trials were measured at slaughter; one unit defined as 1 ng T3 generated/hr/mg protein during incubation with T4 (1.3 fM). In trial 1, TMA in liver and kidney was 2.86 and 1.21 times greater, respectively, for bGH than for placebo treatments. In trial 2, units of TMA in liver homogenates were higher (P less than .05) for bGH (4.14) than for placebo (2.83) treatments and higher (P less than .02) in liver microsomal preparations for bGH (32.7) than for placebo (27.3) treatments. Units of TMA in kidney homogenates were also higher (P less than .10) for bGH (1.48) than for placebo (.87) treatments and higher (P less than .02) in kidney microsomal preparations for bGH (23.0) than for placebo (16.4) treatments. Following acute injection of bGH (trial 3), units of TMA in liver homogenates were higher (P less than .01) for bGH (2.5) than for placebo (1.8) treatments. Plasma T4 (70.0 vs 73.5 ng/ml) and T3 (1.08 vs 1.18 ng/ml) concentrations appeared slightly higher in bGH-treated steers (trial 2) and increased by 20 and .5 ng/ml, respectively, (P less than .01) within 6 to 12 h after acute injection of bGH (trial 3). Concurrently, plasma TSH concentration increased following acute GH injection (trial 3).(ABSTRACT TRUNCATED AT 400 WORDS)     

多壁碳纳米管分散固相萃取结合LC-MS/MS测定饲料中11种β-受体激动剂

本研究建立了采用多壁碳纳米管(MWCNTs)为吸附剂的分散固相萃取(dSPE)净化、液相色谱串联质谱测定饲料中11种β-受体激动剂(克伦特罗、莱克多巴胺、沙丁胺醇、苯乙醇胺A、氯丙那林、妥布特罗、西马特罗、特布他林、马布特罗、班布特罗和喷布特罗)的方法。饲料样品经甲酸水溶液提取后,调节pH值至10,加入50 mgMWCNTs进行分散固相萃取,被吸附的化合物经1.0%甲酸水甲醇(91)洗脱,洗脱液过滤膜后进行LC-MS/MS分析。采用Acquity UPLC BEH C18色谱柱分离,以0.1%甲酸水溶液和甲醇为流动相进行梯度洗脱,电喷雾正电子(ESI+)模式电离,多反应监测(MRM)模式监测,内标法校准进行定量。结果表明:11种β-受体激动剂在0.1～20μg/L浓度范围内呈良好的线性,线性相关系数均大于0.997,猪配合饲料样品中最低定量限为0.05～0.48μg/kg。猪配合饲料中添加0.5～500μg/kgβ-受体激动剂的回收率在89.6%～112.9%,相对标准偏差RSD均小于15%。